To examine the role played by CENPE in ovarian cancer growth, we treated ovarian cancer cell lines with GSK923295, a potent CENPE inhibitor with an inhibitory constant (Ki) of 3.2 nM [55]. The gene discussed is CENPE; the disease is ovarian carcinoma.